- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04217902
VOIES-D-ql - Qualitative Study on Experiences of Diabetes Care Delivery and Planning (VOIES-D-ql)
VOIES-D-ql (Visualization for the Optimization of Interactions and Experiences in Healthcare Services in Diabetes Care)
Population aging and the increase in incidence and prevalence of potentially disabling chronic conditions make health care more and more complex and costly. In this context, timelines are longer and adherence to care provision and health status are more variable - both within and between patients - and care is provided by different health care professionals, as well as services outside the health system, which may work at various levels of service integration. For diabetes, this is especially the case: patients at high risk for multimorbidity interact with multiple health care professionals, such as primary care physicians, diabetes specialists, nurses, nutritionists and therapeutic educators, with different perspectives to treatment. The patient is frequently the only link between the different health care professionals, and very often the main source of information regarding performed procedures, diagnoses and treatment decisions.
A current challenge facing all health care stakeholders, including policy makers, practitioners, businesses, and patients, is to coordinate the available services and integrate care ensuring safety, effectiveness, and comprehensiveness in relation to the needs of individual users across the lifespan. Routine collected data can provide key information to completely assess a patient's health status and thus help evaluating and deciding adapted steps in treatment to stabilize or improve clinical outcomes.
In France, the Dossier Medical Partagé (Shared Medical Record) represents an effort to centralize and improve accessibility, to patients and professionals alike, of medical information. This system is yet little adopted and there is the need for added value initiatives to exploit the tool's potential. In other countries, like the UK, the governmental unit NHSX develops public policies and good practices for the digital transformation of the NHS. In the United States, working groups like the Health Information Technology Working Group, in the National Institute of Diabetes and Digestive and Kidney Diseases, develop electronic care plans using Electronic Health Record data for chronic kidney disease patients. These initiatives, among others, show the necessity of simple, visual communication in order to build a comprehensive care delivery pathway to inform decision and further care planning, according to health goals set by shared decision-making.
This study aims to describe individual experiences of chronic care delivery of people living with diabetes and also from healthcare professionals working in diabetes care from 3 different domains: clinical (relevant clinical criteria necessary for the decision-making process, goal setting and planning), technological (tools used in routine practice and in patients' daily lives), and behavioural (behaviours and interactions that build the patient's pathway and strategies implemented by patients and professionals to help the decision-making process).
Locations of the study : Primary and secondary healthcare facilities and patient associations in Lyon and Grenoble areas
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69003
- Laboratory HESPER EA 7425, University Claude Bernard Lyon 1
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient
- At least 18 years old
- Diagnosed with type 1 or type 2 diabetes according to HAS criteria and confirmed by and endocrinologist since at least one year
- Having had at least one consultation with a health care professional in the last 12 months
- Able to communicate in French
- Able to participate in an interview and not opposing to participate in the study
Professional
- Having at least one year of professional experience in diabetes care
- General practitioner, endocrinologist, diabetologist, intern, nurse, nutritionist or professional specialized in therapeutic education
Exclusion Criteria:
Patient
- Inability to communicate in French
- Institutionalized person
Professional
- Professional not having had at least one consultation with a person living with diabetes in the last 12 months
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
People living with diabetes in Grenoble and Lyon areas
Eligible patients with type 1 or type 2 diabetes 1) during or after hospitalization for decompensation, ketoacidosis, or other emergency or elective interventions such as insulin pump installation, 2) followed in routine care in specialized diabetes services, 3) participating in patient associations.
|
Semi-directed interviews will be conducted with people living with type 1 or type 2 diabetes in person or by phone to assess and describe the care delivery pathway they have been through.
Information on 3 domains will be assessed: clinical (information they consider essential for health care professionals to systematically have access to during consultations and other health-related interventions such as therapeutic education sessions), technological (what kind of digital services and technologies they use or are willing to use), and behavioural (the decision-making process and the key interactions that build the care delivery pathway).
|
Health care professionals working in diabetes care in Grenoble
Health care professionals working with diabetes care in specialized services or ambulatory care.
|
Semi-directed interviews will be conducted with health care professionals working in diabetes care in person or by phone to assess and describe their needs and experiences in diabetes care.
Information on 3 domains will be assessed: clinical (the information they consider to be essential to inform decisions in diabetes care, where and if they currently find that information and problems they might encounter), technological (which software they currently use and how data is input into clinical information systems), and behavioural (how care coordination is currently managed, how interactions with patients and other professionals are undertaken).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Description of individual experiences of patients and health care professionals in diabetes care.
Time Frame: The moment of the interview (Day 0)
|
Socioeconomic status will be assessed, health literacy using the Brief Health Literacy Screening (BHLS), and a semi-directed interview will be undertaken with people living with type 1 or type 2 diabetes.
The latter aims t obtain a description of their experiences concerning how their care delivery pathways were built over time, how health-related decisions are made individually and what data they consider health care professionals they interact with should systematically have access to (considering the 3 domains previously described).
Health care professionals will also be interviewed regarding their experiences and needs in diabetes care, in the shared decision-making process and in establishing care coordination.
|
The moment of the interview (Day 0)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL19_0897
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabete Type 2
-
Rio Grande do Sul State Health Department - SES/RSAgnes Nogueira Gossenheimer; Ana Paula Rigo; Roberto Eduardo SchneidersNot yet recruitingTelemedicine | Diabete Mellitus | Diabete Type 2 | TelehealthBrazil
-
Yale UniversityNational Center for Advancing Translational Sciences (NCATS)WithdrawnDiabete Type 2United States
-
BiolingusChinese University of Hong KongRecruiting
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
National University of SingaporeCompleted
-
Egyptian Chinese UniversityActive, not recruiting
-
University of LiegeEGID, LilleUnknown
-
Spaulding Rehabilitation HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsNot yet recruitingAmputation | Diabete Type 2United States
-
Assiut UniversityNot yet recruiting
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkRecruitingDiabete Type 2France
Clinical Trials on Description of patients' experiences of diabetes care delivery and planning
-
Centre Hospitalier Universitaire de Pointe-a-PitreCompletedType 2 Diabetes Treated With InsulinGuadeloupe
-
University of AarhusRecruiting
-
Hospices Civils de LyonActive, not recruiting
-
Baylor College of MedicineM.D. Anderson Cancer Center; Michael E. DeBakey VA Medical Center; Agency for...CompletedHypertension | Diabetes
-
Fundacio d'Investigacio en Atencio Primaria Jordi...CompletedType 2 Diabetes | Cardiovascular Risk Factor | GenderSpain
-
University Hospital, ToulouseCompleted
-
Oslo University HospitalCompletedCOVID-19 | Critical Care | Intensive Care Units | Health PersonnelNorway
-
Università degli Studi di SassariCompleted
-
Brigham and Women's HospitalPOM Wonderful LLCRecruiting
-
Hospices Civils de LyonCompletedOral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)Gestational DiabetesFrance